Dr. Nackel founded Three-Sixty Advisory Group, LLC (Three-Sixty) in 2007 to help emerging health care services and medical technology companies address growth, performance, and capital challenges. In 2018, he founded Wavemaker Three-Sixty Health (Wavemaker 360) which is a health-care dedicated early-stage venture fund.
“Dr. Nackel brings decades of operating and governance experience to our Board of Directors,” said Dr. Mylea Charvat, CEO of Savonix. “John is a recognized national authority in the healthcare industry and fellow of the American College of Healthcare Executives. We look forward to leveraging his years of expertise as a CEO and a board member of leading healthcare organizations and emerging businesses, to work with our operating team as we continue to establish Savonix as the leader in cognitive assessment in clinical care.”
Prior to Wavemaker 360, Dr. Nackel served as the Chief Executive Officer of Ingenix Consulting (now Optum), a United Health Group (NYSE:UNH) company. He was Global Managing Director of health services at Ernst & Young (now EY) for 25 years and was also the CEO of Sogeti North America, the professional services division of CapGemini.
“I am delighted to join the Savonix team. Savonix has already distinguished itself as a leader in Alzheimer’s, dementia, and brain health. The company delivers the first scientifically proven, consumer-style app that provides valuable information about your brain health and wellness,” said Dr. Nackel.
Dr. Nackel currently serves on the board of directors of the Pennant Group (NASDAQ:PNTG) which provides home health, hospice and assisted living services. Previously he served for 12 years on the Board of the Ensign Group, Inc., (NASDAQ:ENSG) which provides skilled nursing and rehabilitative services and Mercury General (NYSE:MCY), a specialty writer of all risk classifications of automotive insurance.
He earned his bachelor's degree in mathematics and economics from Tufts University, master's degrees in public health and industrial engineering, and a Ph.D. in industrial engineering and health administration from the University of Missouri.
A global leader in cognitive health, Savonix delivers the only digital neuropsychology platform in the market. We provide digital cognitive health solutions for patients, providers, researchers, payers, and Medicare Advantage companies, and empower them to improve health and treatment outcomes. Developed by clinical neuropsychologists and digital health technology experts, the Savonix Cognitive Assessment is an accurate, accessible, and affordable tool available for download on all mobile devices. To learn more about Savonix, visit Savonix.com.